What is GoPath Laboratories?
GoPath Laboratories operates as a sophisticated provider of high-complexity diagnostic services, specializing in the intersection of anatomic pathology and genomic tumor profiling. With a foundation built on over fifty years of collective scientific expertise, the organization maintains a CAP-accredited and CLIA-certified laboratory environment. Their service portfolio is designed to support oncology practices, hospital systems, and biopharmaceutical entities by delivering actionable, data-driven insights. By integrating digital pathology solutions with hereditary cancer testing, GoPath facilitates a more streamlined diagnostic workflow, ultimately enhancing the quality of care for patients navigating complex cancer treatment pathways.
How much funding has GoPath Laboratories raised?
GoPath Laboratories has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in GoPath Laboratories
PPP
Public-Private Partnership
What's next for GoPath Laboratories?
With the recent influx of capital, GoPath Laboratories is poised to transition into a phase of aggressive market expansion and technological refinement. The strategic deployment of these funds will likely focus on enhancing their genomic sequencing throughput and expanding their digital pathology footprint to meet the growing demand for personalized medicine. As the oncology sector continues to prioritize precision diagnostics, GoPath is strategically aligned to leverage its existing laboratory infrastructure to capture additional market share. Future growth initiatives will likely involve deepening partnerships with biopharma innovators to support clinical trials and expanding their reach into broader clinical diagnostic markets, ensuring that their actionable insights remain at the forefront of patient-centric oncology care.
See full GoPath Laboratories company page
